These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35264241)

  • 1. The governance of imported 2019-nCov infections: What can be learned from China's experience?
    Li H; He J; Chen J; Pan S; Feng J; Liu S
    Glob Health Res Policy; 2022 Mar; 7(1):8. PubMed ID: 35264241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective.
    Gong F; Xiong Y; Xiao J; Lin L; Liu X; Wang D; Li X
    Front Med; 2020 Apr; 14(2):220-224. PubMed ID: 32166600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and Control Measures for Imported SARS-CoV-2 Transmission During the Postpandemic Period in Shenzhen, China.
    He X; Gong F; Sun X; Hu G; Lin J
    Disaster Med Public Health Prep; 2022 Mar; 17():e143. PubMed ID: 35241200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Containment: Comparisons and Suggestions for Global Response.
    Cheng S; Zhao Y; Kaminga AC; Wang X; Zhang X; Xu H
    Inquiry; 2022; 59():469580221086142. PubMed ID: 35584986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's practice to prevent and control COVID-19 in the context of large population movement.
    Xu TL; Ao MY; Zhou X; Zhu WF; Nie HY; Fang JH; Sun X; Zheng B; Chen XF
    Infect Dis Poverty; 2020 Aug; 9(1):115. PubMed ID: 32814591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel coronavirus outbreak: what can be learned from China in public reporting?
    Li H; Chen X; Huang H
    Glob Health Res Policy; 2020; 5():9. PubMed ID: 32166128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics and quarantine assessment of imported international COVID-19 cases, March to December 2020, Chengdu, China.
    Zhang W; Yue Y; Hu M; Du C; Wang C; Tuo X; Jiang X; Fan S; Chen Z; Chen H; Liang X; Luan R
    Sci Rep; 2022 Dec; 12(1):21132. PubMed ID: 36477091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China's global engagement to fight the novel coronavirus pandemic.
    Song W
    Glob Health Res Policy; 2020; 5():44. PubMed ID: 33083550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020.
    Bajema KL; Oster AM; McGovern OL; Lindstrom S; Stenger MR; Anderson TC; Isenhour C; Clarke KR; Evans ME; Chu VT; Biggs HM; Kirking HL; Gerber SI; Hall AJ; Fry AM; Oliver SE; ;
    MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(6):166-170. PubMed ID: 32053579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.
    Lu G; Cao Y; Zhang D; Zhang Y; Xu Y; Lu Y; Chen Q; Zhu G; Yan J; Müller O; Cao J
    Global Health; 2022 Jun; 18(1):64. PubMed ID: 35729642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.
    Ding D; Zhang R
    Front Public Health; 2022; 10():857003. PubMed ID: 35359767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
    Wu J; Liu J; Li S; Peng Z; Xiao Z; Wang X; Yan R; Luo J
    Travel Med Infect Dis; 2020; 37():101673. PubMed ID: 32311437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's community-based crisis management model for COVID-19: A zero-tolerance approach.
    Shangguan Z; Wang MY
    Front Public Health; 2022; 10():880479. PubMed ID: 35937237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel coronavirus outbreak in Wuhan, China.
    Zhu H; Wei L; Niu P
    Glob Health Res Policy; 2020; 5():6. PubMed ID: 32226823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Zhou L; Wu Z; Li Z; Zhang Y; McGoogan JM; Li Q; Dong X; Ren R; Feng L; Qi X; Xi J; Cui Y; Tan W; Shi G; Wu G; Xu W; Wang X; Ma J; Su X; Feng Z; Gao GF
    Clin Infect Dis; 2021 Jan; 72(2):332-339. PubMed ID: 33501949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.